Senior insider sale
Chief Technology Officer at KYVERNA THERAPEUTICS, INC. — senior position signals high conviction
$23.3K
2.46K shares
What this filing means
WALKER KAREN MARIE plans to sell 2.46K shares of KYVERNA THERAPEUTICS, INC. valued at approximately $23.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001950047-26-003454
Officer· Chief Technology Officer
Since Feb 2024
2.46K
Shares to sell
$23.3K
Approx. market value
2.46K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/11/2026
2.46KTotal acquired2.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/11/2026 | Restricted Stock Units N/A | 2.46K | — |
| Total | 2.46K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.46K
Market value
$23.3K
4/14/2026
Total
Units
2.46K
Value
$23.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/14/2026 | 2.46K | $23.3K | NASDAQ | Planned |
| Total | 2.46K | $23.3K | ||